A complete appraisal, in physiologic terms, of the mechanism of pulmonary hypertension in heart disease must take into account these three factors, which may operate independently or ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

Pulmonary arterial hypertension (PAH ... or it is caused by heart or lung diseases or by certain drugs and infections. About half of PAH cases have no known cause. When a condition's cause ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Supporters will unite on May 5 to mark World Pulmonary Hypertension Day, with a focus this year on early diagnosis.

Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...

A study was conducted to determine the relationship between health care utilization and cardiovascular complication ...

Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease.

The following is a summary of “Right atrial reservoir strain as an early predictor of pulmonary hypertension development in ...

E-cigarette use is linked to increased risk of COPD and possibly hypertension, though less harmful than traditional smoking, ...

Dr Ahmed Fahim discusses the UK Idiopathic Pulmonary Fibrosis Registry and how its findings enhance understanding and ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...